Delayed P300 latency correlates with abnormal test of variables of attention (TOVA) in adults and predicts early cognitive decline in a clinical setting

Advances in Therapy

Volumn 23, Issue 4, 2006, Pages 582-600

  Braverman, Eric R ^a   Chen, Thomas J H ^b,c   Schoolfield, John ^d   Martinez Pons, Manuel ^e   Arcuri, Vanessa ^a   Varshavskiy, Michael ^a   Gordon, Cory A ^f   Mengucci, Julie ^f   Blum, Seth H ^f   Meshkin, Brian ^g   Downs, Bernard W ^h   Blum, Kenneth ^a,g,i  

^a PATH Foundation   (United States)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f Synaptamine Inc   (United States)

^g Salugen Inc   (United States)

^h Allied Nutraceutical Research   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Attention complaints; P300; QEEG; TOVA; Wechsler Memory Scale

Indexed keywords

ADULT; AGED; AGING; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; SEX DIFFERENCE; TEST OF VARIABLES ATTENTION; WECHSLER MEMORY SCALE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; DEMENTIA; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; RISK FACTORS; SEX FACTORS;

EID: 33750984513     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850047     Document Type: Article

References (70)

1. Braverman ER, Blum K. P300 (latency) event-related potential: an accurate predictor of memory impairment. Clin Electroencephalogr. 2003;34:124-139.
2. Johnstone B, Hogg JR, Schopp LH, Kapila C, Edwards S. Neuropsychological deficit profiles in senile dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2002;17:273-281.
3. Arnaiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand Suppl. 2003;179:34-41.
4. Boone KB, Miller BL, Swartz R, Lu P, Lee A. Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc. 2003;9:698-709.
5. Jackson GR, Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin. 2003;21:709-728.
6. Knox MR, Lacritz LH, Chandler MJ, Munro Cullum C. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease. Clin Neuropsychol. 2003; 17:216-219.
7. Tales A, Muir J, Jones R, Bayer A, Snowden RJ. The effects of saliency and task difficulty on visual search performance in ageing and Alzheimer's disease. Neuropsychologia. 2004;42:335-345.
8. Sheridan PL, Solomont J, Kowall N, Hausdorff JM. Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc. 2003;51:1633-1637.
9. Bennett DA. Update on mild cognitive impairment. Curr Neurol Neurosci Rep. 2003;3:379-384.
10. Papagno C, Allegra A, Cardaci M. Time estimation in Alzheimer's disease and the role of the central executive. Brain Cogn. 2004;54:18-23.
11. Braverman ER, Chen TJH, Rayannavar A, et al. Test of Variables of Attention (TOVA): an accurate predictor of early attentional complaints in a clinical setting. J Psychiatr Res. 2006 (submitted).
12. Grundman M, Petersen RC, Ferris SH, et al. Alzheimer's disease cooperative study: mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
13. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290-1308.
14. Petersen RC. Aging, mild cognitive impairment, and Alzheimer's disease. Neurol Clin. 2000; 18:789-806.
15. Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 2000;15:93-101.
16. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405.
17. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 2002;59:1034-1041.
18. McCracken J. Attention-deficit disorders. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2000:2679-2685.
19. McCracken J. Attention-deficit disorders. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2000:2688-2692.
20. Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry. 1995;152: 1793-1799.
21. Hinshaw SP. Academic underachievement, attention deficits, and aggression: comorbidity and implications for intervention. J Consult Clin Psychol. 1992;60:893-903.
22. Silver LB. The relationship between learning disabilities, hyperactivity, distractibility, and behavioral problems: a clinical analysis. J Am Acad Child Psychiatry. 1981;20:385-397.
23. Silverstein ML, Mavrolefteros G, Turnbull A. Premorbid factors in relation to motor, memory, and executive functions deficits in adult schizophrenia. Schizophr Res. 2003;61:271-280.
24. Riordan HJ, Flashman LA, Saykin AJ, Frutiger SA, Carroll KE, Huey L. Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Arch Clin Neuropsychol. 1999;14:217-233.
25. Harmer CJ, Clark L, Grayson L, Goodwin GM. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia. 2002;40:1586-1590.
26. Katz LJ, Wood DS, Goldstein G, Auchenbach RC, Geckle M. The utility of neuropsychological tests in evaluation of attention-deficit/hyperactivity disorder (ADHD) versus depression in adults. Assessment. 1998;5:45-52.
27. van der Feltz-Cornelis CM. Intractable obsessive-compulsive disorder: comorbidity with unrecognized adult attention-deficit hyperactivity disorder? J Nerv Ment Dis. 1999;187:243-245.
28. Johnson DE, Epstein JN, Waid LR, Latham PK, Voronin KE, Anton RF. Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2001;16:587-604.
29. Ossmann JM, Mulligan NW. Inhibition and attention deficit hyperactivity disorder in adults. Am J Psychol. 2003;116:35-50.
30. Estevez-Gonzalez A, Garcia-Sanchez C, Boltes A, et al. Sustained attention in the preclinical phase of Alzheimer's disease. Rev Neurol. 2003;36:829-832.
31. King JA, Barkley RA, Delville Y, Ferris CF. Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav Brain Res. 2000;107:35-43.
32. Mihailescu S, Drucker-Colin R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res. 2000;31:131-144.
33. Adesman AR, Altshuler LA, Lipkin PH, Walco GA. Otitis media in children with learning disabilities and in children with attention deficit disorder with hyperactivity. Pediatrics. 1990; 85(3 Pt 2):442-446.
34. Van der Werf YD, Scheltens P, Lindeboom J, et al. Deficits of memory, executive functioning and attention following infarction in the thalamus: a study of 22 cases with localised lesions. Neuropsychologia. 2003;41:1330-1344.
35. Channon S, Pratt P, Robertson MM. Executive function, memory, and learning in Tourette's syndrome. Neuropsychology. 2003;17:247-254.
36. Traykov L, Baudic S, Thibaudet MC, Rigaud AS, Smagghe A, Boller F. Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:26-32.
37. Wester K, Irvine DR, Hugdahl K. Auditory laterality and attentional deficits after thalamic haemorrhage. J Neurol. 2001;248:676-683.
38. Nag S, Rao SL. Remediation of attention deficits in head injury. Neurol India. 1999;47:32-39.
39. Naumann A, Bierbrauer J, Przuntek H, Daum I. Attentive and preattentive processing in narcolepsy as revealed by event-related potentials (ERPs). Neuroreport. 2001;12:2807-2811.
40. Piras MR, Magnano I, Canu ED, et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry. 2003;74:878-885.
41. Shahar E, Shinawi M. Neurocristopathies presenting with neurologic abnormalities associated with Hirschsprung's disease. Pediatr Neurol. 2003;28:385-391.
42. Lahat E, Broide E, Leshem M, Evans S, Scapa E. Prevalence of celiac antibodies in children with neurologic disorders. Pediatr Neurol. 2000;22:393-396.
43. Fallon BA, Kochevar JM, Gaito A, Nields JA. The underdiagnosis of neuropsychiatric Lyme disease in children and adults. Psychiatr Clin North Am. 1998;21:693-703, viii.
44. Stein MA, Weiss RE. Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2003;28:304-316.
45. Saxby BK, Harrington F, McKeith IG, Wesnes K, Ford GA. Effects of hypertension on attention, memory, and executive function in older adults. Health Psychol. 2003;22:587-591.
46. Trojano L, Antonelli Incalzi R, Acanfora D, et al. Congestive heart failure Italian study investigators. Cognitive impairment: a key feature of congestive heart failure in the elderly. J Neurol. 2003;250: 1456-1463.
47. Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J Neurol. 2003;250:325-332.
48. Coker LH, Shumaker SA. Type 2 diabetes mellitus and cognition: an understudied issue in women's health. J Psychosom Res. 2003;54:129-139.
49. Gayton WF, Bailey C, Wagner A, Hardesty VA. Relationship between childhood hyperactivity and accident proneness. Percept Mot Skills. 1986;63:801-802.
50. Barkley RA. Advancing age, declining ADHD. Am J Psychiatry. 1997;154:1323-1325.
51. Hansen C, Weiss D, Last CG. ADHD boys in young adulthood: psychosocial adjustment. J Am Acad Child Adolesc Psychiatry. 1999;38:165-171.
52. Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry. 2003;42:1415-1423.
53. Woodward LJ, Fergusson DM, Horwood LJ. Driving outcomes of young people with attentional difficulties in adolescence. J Am Acad Child Adolesc Psychiatry. 2000;39:627-634.
54. Green M, Wong M, Atkins D, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Technical Review No. 3. Rockville, Md: Agency for Health Care Policy and Research; 1999. AHCPR Publication No. 99-0050.
55. Szatmari P, Offord DR, Boyle MH. Correlates, associated impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J Child Psychol Psychiatry. 1989;30:205-217.
56. Blum K, Braverman ER, Holder JM, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs. 2000;32(suppl i-iv):1-112.
57. Noble EP, Berman SM, Ozkaragoz TZ, Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet. 1994;54:658-668.
58. Kirley A, Lowe N, Hawi Z, et al. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet. 2003;121:50-54.
59. Manor I, Tyano S, Eisenberg J, et al. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry. 2002;7:790-794.
60. Conners CK. A teacher rating scale for use in drug studies with children. Am J Psychiatry. 1969; 126:884-888.
61. Forbes GB. Clinical utility of the test of variables of attention (Tova) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol. 1998;54:461-476.
62. Monastra VJ, Lubar JF, Linden M. The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies. Neuropsychology. 2001;15:136-144.
63. Lindau M, Jelic V, Johansson SE, Anderson C, Wahlund LO, Almkvist O. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and dementia disease. Demeter Geriatr Cogn Disord. 2003;15:106-114.
64. Rodriguez G, Vitali P, Canfora M, et al. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease. Clin Neurophysiol. 2004;115:39-49.
65. McDaniel MA, Maier SF, Einstein GO. "Brain-specific" nutrients: a memory cure? Nutrition. 2003;19:957-975.
66. Naumann A, Bierbrauer J, Przuntek H, Daum I. Attentive and preattentive processing in narcolepsy as revealed by event-related potentials (ERPs). Neuroreport. 2001;12:2807-2811.
67. Burkhardt MS, Foster JK, Clarnette RM, et al. Interaction between testosterone and apolipoprotein E epsilon 4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91:1168-1172.
68. Braverman ER, Blum Chen, Marinez-Pons M, Arcuria V, Meshkin B. Low human plasma levels of sex hormones and human growth factor(s) correlate to cognitive decline marked by prolonged P300 latency as a function of gender in a clinical setting: a paradigm shift. Presented at: Endocrine Society 88th Annual Meeting; June 24-27, 2006; Boston, Mass.
69. Conners CK. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry. 1998;59(suppl 7):24-30.
70. Rasmussen NH. Diagnosis of attention deficit disorders, hyperactivity disorders and DAMP in children. Ugeskr Laeger. 2002;164:4631-4636.